Accounting Paraflux Inc., a pharmaceutical company, reported earnings per share of 0.9, a return on assets of

Fantastic news! We've Found the answer you've been seeking!

Question:

Accounting Paraflux Inc., a pharmaceutical company, reported earnings per share of €0.9, a return on assets of 13%, a debt-to-equity ratio of 40%, a pre-tax interest rate of 8%, and a retention ratio of 85% for the previous year. Moreover, the company had registered a growth in earnings per share of 50% in the past five years. Assuming that the tax rate is 25% and that these figures will be sustained in the future, the expected growth rate in free cash flow to equity (FCFE) will be:

a. 10.36%

b. 16.53%

c. 11.22%

d. None of the Above